ALL and CLL updates at ASCO 2021
Zaid Abdel Rahman, MD, Mayo Clinic, Jacksonville, FL, discusses highlights from the American Society of Clinical Oncology (ASCO) 2021 Virtual meeting, including the results of a study evaluating chemotherapy-free regimens in Philadelphia positive acute lymphoblastic leukemia (ALL), as well as the findings from the ZUMA-3 trial (NCT02614066), also in ALL. In addition, Dr Rahman talks on the results of a study comparing the use of acalabrutinib versus ibrutinib in previously treated patients with chronic lymphocytic leukemia (CLL). This interview was conducted at the American Society of Clinical Oncology (ASCO) 2021 Virtual Meeting.
Watch video ALL and CLL updates at ASCO 2021 online without registration, duration hours minute second in high quality. This video was added by user VJHemOnc – Video Journal of Hematology & HemOnc 14 June 2021, don't forget to share it with your friends and acquaintances, it has been viewed on our site 238 once and liked it 2 people.